{"id":"https://openalex.org/W2088148024","doi":"https://doi.org/10.2165/00003088-199732010-00004","title":"Bioequivalence of Controlled-Release Calcium Antagonists","display_name":"Bioequivalence of Controlled-Release Calcium Antagonists","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W2088148024","doi":"https://doi.org/10.2165/00003088-199732010-00004","mag":"2088148024","pmid":"https://pubmed.ncbi.nlm.nih.gov/9012557"},"language":"en","primary_location":{"id":"doi:10.2165/00003088-199732010-00004","doi":"https://doi.org/10.2165/00003088-199732010-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003088-199732010-00004","pdf_url":null,"source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075482338","display_name":"Robert Schall","orcid":"https://orcid.org/0000-0002-4145-3685","observed_orcids":["https://orcid.org/0000-0002-4145-3685"]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":true,"raw_author_name":"Robert Schall","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa. GNFMRS@FRM.UOVS.AC.ZA","FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa. GNFMRS@FRM.UOVS.AC.ZA","institution_ids":["https://openalex.org/I26999989"]},{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108492952","display_name":"F M\u00fcller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Frank R. M\u00fcller","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, PO Box 339 (G6), Bloemfontein, Free State, 9300, South Africa","FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, PO Box 339 (G6), Bloemfontein, Free State, 9300, South Africa","institution_ids":["https://openalex.org/I26999989"]},{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108588442","display_name":"Frank O. M\u00fcller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"F. Otto M\u00fcller","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, PO Box 339 (G6), Bloemfontein, Free State, 9300, South Africa","FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, PO Box 339 (G6), Bloemfontein, Free State, 9300, South Africa","institution_ids":["https://openalex.org/I26999989"]},{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110114769","display_name":"H. G. Luus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Herman G. Luus","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, PO Box 339 (G6), Bloemfontein, Free State, 9300, South Africa","FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, PO Box 339 (G6), Bloemfontein, Free State, 9300, South Africa","institution_ids":["https://openalex.org/I26999989"]},{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Division of Biometry, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075482338"],"corresponding_institution_ids":["https://openalex.org/I26999989"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":2.3276,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.90006734,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"32","issue":"1","first_page":"75","last_page":"89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.79830002784729,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.79830002784729,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.08760000020265579,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.027499999850988388,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9850000143051147},{"id":"https://openalex.org/keywords/controlled-release-formulation","display_name":"controlled-release formulation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9670000076293945},{"id":"https://openalex.org/keywords/generic-drug-approval","display_name":"generic drug approval","score":0.6290000081062317},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.5540000200271606},{"id":"https://openalex.org/keywords/90-confidence-interval","display_name":"90% confidence interval","score":0.9240000247955322},{"id":"https://openalex.org/keywords/food-effects-on-drug-absorption","display_name":"food effect on absorption","score":0.7020000219345093},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.8429999947547913},{"id":"https://openalex.org/keywords/stereoselective-pharmacokinetics","display_name":"stereoselective pharmacokinetics","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.9946044683456421},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.8455522060394287},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6404375433921814},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5606311559677124},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5519296526908875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5275138020515442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1957060694694519}],"mesh":[{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017275","descriptor_name":"Isradipine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/00003088-199732010-00004","doi":"https://doi.org/10.2165/00003088-199732010-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003088-199732010-00004","pdf_url":null,"source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:9012557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9012557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W5590055","https://openalex.org/W42331035","https://openalex.org/W151882183","https://openalex.org/W155261558","https://openalex.org/W1527013698","https://openalex.org/W1569804375","https://openalex.org/W1966594273","https://openalex.org/W1969704561","https://openalex.org/W1996109895","https://openalex.org/W1996693517","https://openalex.org/W2006783040","https://openalex.org/W2009990022","https://openalex.org/W2017733150","https://openalex.org/W2030435316","https://openalex.org/W2043916014","https://openalex.org/W2045189858","https://openalex.org/W2049219403","https://openalex.org/W2062741616","https://openalex.org/W2069954747","https://openalex.org/W2073109804","https://openalex.org/W2083973309","https://openalex.org/W2090719682","https://openalex.org/W2092805838","https://openalex.org/W2106073810","https://openalex.org/W2122296694","https://openalex.org/W2147067030","https://openalex.org/W2147236245","https://openalex.org/W2151164119","https://openalex.org/W2265479043","https://openalex.org/W2265990226","https://openalex.org/W2277026843","https://openalex.org/W2298006004","https://openalex.org/W2314704434","https://openalex.org/W2398846607","https://openalex.org/W2413737953","https://openalex.org/W2414817205","https://openalex.org/W2416437239","https://openalex.org/W2417013200","https://openalex.org/W2434328716","https://openalex.org/W2474005789","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2011804350","https://openalex.org/W7025615519","https://openalex.org/W7027116356","https://openalex.org/W1988238372","https://openalex.org/W2008920191","https://openalex.org/W2220073056","https://openalex.org/W1569804375","https://openalex.org/W2600803474","https://openalex.org/W2184263713","https://openalex.org/W1965140853"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}